BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 8230452)

  • 1. Poliovirus capsid proteins derived from P1 precursors with glutamine-valine cleavage sites have defects in assembly and RNA encapsidation.
    Ansardi DC; Morrow CD
    J Virol; 1993 Dec; 67(12):7284-97. PubMed ID: 8230452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino acid substitutions in the poliovirus maturation cleavage site affect assembly and result in accumulation of provirions.
    Ansardi DC; Morrow CD
    J Virol; 1995 Mar; 69(3):1540-7. PubMed ID: 7853487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles.
    Ansardi DC; Porter DC; Morrow CD
    J Virol; 1992 Jul; 66(7):4556-63. PubMed ID: 1318418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the poliovirus P1 capsid precursor at arginine residues VP4-ARG34, VP3-ARG223, and VP1-ARG129 affect virus assembly and encapsidation of genomic RNA.
    Ansardi DC; Luo M; Morrow CD
    Virology; 1994 Feb; 199(1):20-34. PubMed ID: 8116243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complementation of a poliovirus defective genome by a recombinant vaccinia virus which provides poliovirus P1 capsid precursor in trans.
    Ansardi DC; Porter DC; Morrow CD
    J Virol; 1993 Jun; 67(6):3684-90. PubMed ID: 8388519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encapsidation of poliovirus replicons encoding the complete human immunodeficiency virus type 1 gag gene by using a complementation system which provides the P1 capsid protein in trans.
    Porter DC; Ansardi DC; Morrow CD
    J Virol; 1995 Mar; 69(3):1548-55. PubMed ID: 7853488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coinfection with recombinant vaccinia viruses expressing poliovirus P1 and P3 proteins results in polyprotein processing and formation of empty capsid structures.
    Ansardi DC; Porter DC; Morrow CD
    J Virol; 1991 Apr; 65(4):2088-92. PubMed ID: 1848318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role for the P4 amino acid residue in substrate utilization by the poliovirus 3CD proteinase.
    Blair WS; Semler BL
    J Virol; 1991 Nov; 65(11):6111-23. PubMed ID: 1656088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a short, highly conserved, motif required for picornavirus capsid precursor processing at distal sites.
    Kristensen T; Belsham GJ
    PLoS Pathog; 2019 Jan; 15(1):e1007509. PubMed ID: 30657784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cellular cofactor facilitates efficient 3CD cleavage of the poliovirus P1 precursor.
    Blair WS; Li X; Semler BL
    J Virol; 1993 Apr; 67(4):2336-43. PubMed ID: 8383245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and site-directed mutagenesis of the primary (2A/2B) cleavage site of the hepatitis A virus polyprotein: functional impact on the infectivity of HAV RNA transcripts.
    Martin A; Escriou N; Chao SF; Girard M; Lemon SM; Wychowski C
    Virology; 1995 Oct; 213(1):213-22. PubMed ID: 7483265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of deletion mutants indicates that the 2A polypeptide of hepatitis A virus participates in virion morphogenesis.
    Cohen L; Bénichou D; Martin A
    J Virol; 2002 Aug; 76(15):7495-505. PubMed ID: 12097562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Encapsidation and serial passage of a poliovirus replicon which expresses an inactive 2A proteinase.
    Ansardi DC; Pal-Ghosh R; Porter D; Morrow CD
    J Virol; 1995 Feb; 69(2):1359-66. PubMed ID: 7815522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cleavage sites within the poliovirus capsid protein precursors.
    Larsen GR; Anderson CW; Dorner AJ; Semler BL; Wimmer E
    J Virol; 1982 Jan; 41(1):340-4. PubMed ID: 6283126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poliovirus protein 3CD is the active protease for processing of the precursor protein P1 in vitro.
    Jore J; De Geus B; Jackson RJ; Pouwels PH; Enger-Valk BE
    J Gen Virol; 1988 Jul; 69 ( Pt 7)():1627-36. PubMed ID: 2839599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of poliomyelitis subviral particles in the yeast Saccharomyces cerevisiae.
    Jore JP; Veldhuisen G; Kottenhagen M; Pouwels PH; Foriers A; Rombaut B; Boeyé A
    Yeast; 1994 Jul; 10(7):907-22. PubMed ID: 7985418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maturation of the hepatitis A virus capsid protein VP1 is not dependent on processing by the 3Cpro proteinase.
    Martin A; Bénichou D; Chao SF; Cohen LM; Lemon SM
    J Virol; 1999 Aug; 73(8):6220-7. PubMed ID: 10400711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of poliovirus-like particles by recombinant baculoviruses expressing the individual VP0, VP3, and VP1 proteins by comparison to particles derived from the expressed poliovirus polyprotein.
    Bräutigam S; Snezhkov E; Bishop DH
    Virology; 1993 Feb; 192(2):512-24. PubMed ID: 8380663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cleavages at the three junctions within the foot-and-mouth disease virus capsid precursor (P1-2A) by the 3C protease are mutually independent.
    Kristensen T; Newman J; Guan SH; Tuthill TJ; Belsham GJ
    Virology; 2018 Sep; 522():260-270. PubMed ID: 30055516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Processing of the VP1/2A junction is not necessary for production of foot-and-mouth disease virus empty capsids and infectious viruses: characterization of "self-tagged" particles.
    Gullberg M; Polacek C; Bøtner A; Belsham GJ
    J Virol; 2013 Nov; 87(21):11591-603. PubMed ID: 23966400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.